Sangamo Therapeutics

IPO

Sangamo Therapeutics is a biotech company in Brisbane, United States, founded in 1995. It has raised $168.5M across 5 rounds, most recently a $25.0M Corporate Round in December 2025.

Sangamo Therapeutics, Inc. | Pioneering Genetic Cures

Employees
201–500
Founded
1995
Business Model
B2B
Total Funding
$168.5M
Last Round
$25.0M Corporate RoundDec 2025
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds for this company. The full record is or through the API.

About

Sangamo Therapeutics is a genomic medicine company that translates ground-breaking science into medicines for patients with severe genetic diseases. Using proprietary zinc finger protein technology, modular integrase systems, and gene delivery platforms, the company pursues potential genomic cures across rare disease areas including neurology, hematology, and metabolic disorders. Sangamo collaborates with major pharmaceutical partners to advance its clinical pipeline addressing conditions such as Fabry disease, hemophilia A, and small fiber neuropathy.

Summary

It lists 201–500 employees. It has raised $168.5M in total across 5 rounds, most recently a $25.0M Corporate Round in Dec 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundDec 2025
$25.0M

Sign up to see all 6 events

Funding: Series C through Corporate Round. Amounts, valuations, and investors where available.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sangamo Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sangamo-therapeutics"><img src="https://indexed.vc/api/badge/company/sangamo-therapeutics" alt="Sangamo Therapeutics on Indexed.vc" width="260" height="76" /></a>